LC
BMY icon

Lourd Capital’s Bristol-Myers Squibb BMY Stock Holding History

Lourd Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$607K Buy
13,374
+260
+2% +$12.1K 0.06% 54
2019
Q1 		$626K Sell
13,114
-20,015
-60% -$997K 0.06% 51
2018
Q4 		$1.72M Sell
33,129
-2,215
-6% -$119K 0.13% 34
2018
Q3 		$2.19M Buy
35,344
+509
+1% +$30.2K 0.14% 31
2018
Q2 		$1.93M Sell
34,835
-2,056
-6% -$111K 0.27% 31
2018
Q1 		$2.33M Sell
36,891
-68
-0.2% -$4.37K 0.31% 25
2017
Q4 		$2.27M Buy
36,959
+23,159
+168% +$1.45M 0.15% 31
2017
Q3 		$880K Buy
13,800
+131
+1% +$7.65K 0.08% 41
2017
Q2 		$762K Sell
13,669
-300
-2% -$16.3K 0.07% 40
2017
Q1 		$760K Buy
13,969
+1,735
+14% +$95.2K 0.07% 42
2016
Q4 		$715K Buy
12,234
+515
+4% +$28.2K 0.07% 39
2016
Q3 		$632K Sell
11,719
-595
-5% -$38.2K 0.07% 38
2016
Q2 		$906K Buy
12,314
+81
+0.7% +$5.72K 0.26% 36
2016
Q1 		$781K Buy
12,233
+773
+7% +$48.7K 0.09% 42
2015
Q4 		$788K Buy
11,460
+687
+6% +$45.4K 0.08% 46
2015
Q3 		$638K Buy
10,773
+162
+2% +$10.3K 0.07% 47
2015
Q2 		$706K Buy
10,611
+103
+1% +$6.79K 0.07% 50
2015
Q1 		$678K Buy
10,508
+87
+0.8% +$5.45K 0.07% 52
2014
Q4 		$615K Buy
10,421
+177
+2% +$9.98K 0.06% 54
2014
Q3 		$524K Buy
10,244
+195
+2% +$9.74K 0.05% 58
2014
Q2 		$487K Buy
10,049
+49
+0.5% +$2.42K 0.05% 63
2014
Q1 		$520K Hold
10,000
– – 0.06% 55
2013
Q4 		$532K Hold
10,000
– – 0.06% 57
2013
Q3 		$463K Sell
10,000
-811
-8% -$35.6K 0.05% 58
2013
Q2 		$483K Buy
+10,811
New +$469K 0.06% 55

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lourd Capital's BMY Position: Q2 2019 in Review

Lourd Capital increased its Bristol-Myers Squibb (BMY) stake by 2% in Q2 2019, buying an estimated $12.1K and bringing the position to 13,374 shares worth $607K. The position accounts for 0.06% of the portfolio, ranked #54.

Lourd Capital first reported a position in BMY in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.33M in Q1 2018. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Lourd Capital held 13,374 shares of Bristol-Myers Squibb worth $607K as of Q2 2019.
  • Lourd Capital bought 260 Bristol-Myers Squibb shares in Q2 2019, an estimated $12.1K.
  • Bristol-Myers Squibb made up 0.06% of Lourd Capital's portfolio in Q2 2019, its #54 holding.
  • Lourd Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 25 quarters since.
  • Lourd Capital's Bristol-Myers Squibb position peaked at $2.33M in Q1 2018.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Lourd Capital's 13F filing for Q2 2019, filed 11 Jul 2019.